definiens: PfIZer Excluded Patents " means claims of any Patents that [COMPANY] or any of its Affiliates own, have under license or otherwise Control to the extent that they ( a ) claim ( i ) one or more Particular Antibodies, or the Exploitation of such Particular Antibody(ies ), ( ii ) a composition comprising one or more Particular Antibodies or the Exploitation of such a composition, ( iii ) a nucleic acid sequence or host cell that specifically codes for, incorporates, expresses or secretes one or more Particular Antibodies, ( iv ) the use of a nucleic acid sequence or host cell or other composition of matter to make ( including to manufacture, formulate, purify, express, recover and secrete ) one or more Particular Antibodies, ( v ) a method of making ( including manufacturing, formulating, purifying, expressing, recovering, and secreting ) one or more Particular Antibodies or a composition comprising such Particular Antibody(ies ), or ( vi ) a method of using one or more Particular Antibodies or a composition comprising such Particular Antibody(ies ), or ( b ) validly claim priority to a Patent filed on or before September 15, 2004 and claim one or more Particular Antibodies, whether specifically or generally, together with, or otherwise in combination with, a specific therapeutic or prophylactic composition of matter, whether in a fixed dosage form or as a combination therapy, wherein the composition of matter is recited in the claim by a specific name, specific compositional description, specific protein structure or specific chemical structure, or the Exploitation of the foregoing, or ( c ) validly claim priority to a Patent filed after September 15, 2004 and claim one or more Antibodies, whether specifically or generally, together with, or otherwise in combination with, one or more antibodies ( other than an Antibody ) or fragment(s ) thereof, whether in a fixed dosage form or as a combination therapy, or the Exploitation of the foregoing . Without limiting the foregoing, [COMPANY] Excluded Patents shall include any Patents to the extent that they claim or cover [ a CpO oligonucleotide, whether alone or in combillation with, Antibodie, s or other compositions of matter, or uses thereof, ] including claims that validly claim priority to [ US provisional patent application No . 60/697,082, filed July 7, 2005, including PCT / US2006/027711, filed June'll, 2006 / now published : as W02007 / Q08463Ai on January . 18~ ' 2007 ; Taiwan Patent ApplicationNo~ 951241'52, filed Jidj{J " 7006 ; ' and Atgentina Patent Application No . P0601 02913,filed July 6, 2006, to the extent'thatstich claims claim a CpO. oligonucleotide, whether alone or in cQmbination with . Antibodies or oth.~, comppsitions of matter, or uses thereof ]